Table 1. Summary of patient data and Bak and Bax expression.
Patient | Biopsy location | Age | Sex | Bak | Bax |
---|---|---|---|---|---|
1 | LN, supraclavicular | 65 | M | >75% | >75% |
2 | Chest/breast mass | 23 | M | >75% | 50–75% w |
3 | Small bowel | 61 | M | >75% | 50–75% w |
4 | Tonsil | 20 | M | 50–75% | 25–50% w |
5 | LN, axilla | 25 | M | 50–75% | 5–25% |
6 | LN, cervical | 54 | F | 50–75% | 5–25% |
7 | LN, axilla, gall bladder | 46 | M | 25–50% | 5–25% |
8 | LN, inguinal | 86 | M | 25–50% | 25–50% |
9 | LN, supraclavicular | 65 | M | 5–25% | <5% |
10 | LN, cervical | 6 | M | 50–75% | 50–75% |
11 | LN, cervical | 25 | M | 5–25% | 5–25% |
12 | Cecum, terminal ileum | 10 | M | > 75% | 50–75% |
13 | LN, inguinal | 39 | M | 25–50% | 5–25% |
14 | Nasal cavity | 6 | M | 5–25% | 5–25% |
15 | Adnexal mass | 28 | F | >75% | 50–75% w |
16 | LN, cervical | 16 | M | 25–50% | 25–50% |
Samples were stained and expression expressed in quartiles as outlined in the “Materials and Methods” section. LN, lymph node.